Erweiterte Funktionen


Oxford Technology 3 VCT plc : Half-yearly report




19.10.16 12:15
dpa-AFX


Oxford Technology 3 Venture Capital Trust Plc



Unaudited Half-Yearly Report


For the period


1 March 2016 to 31 August 2016




Financial Headlines



  6 Months Ended Year Ended 31 August 2016 29 February 2016



Net Assets at Period End £5.92m £6.89m



Net Asset Value per Share 87.3p 101.6p



Cumulative Dividend per Share 32.0p 17.0p



Total NAV Return per Share 119.3p 118.6p



Share Price 57.5p 62.5p



Earnings per Share 0.7p 13.0p









Company Number: 4351474 Registered Address: The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA



Statement on behalf of the Board


I am pleased to present the unaudited results for the six month period ended 31 August 2016.


Results and dividends The Company's net asset value per share has reduced from 101.6p at 29 February 2016 by 14.3p to 87.3p at 31 August 2016. The underlying NAV per share rose by 0.7p but was offset by the payment of a 15.0p interim dividend per share on 13 May 2016. Further dividends are likely to require a profitable investee company exit.


Portfolio review The new VCT rules have not prevented us from investing £709k to support our existing portfolio companies. We exercised our warrants in Ixaris for £425k along with the major shareholder in advance of their expiry date at an attractive discount, thereby not only preventing dilution but also slightly increasing our equity percentage. The valuation of our share of Ixaris has been increased by £529k. We invested £200k in Plasma Antennas to position them for a further funding round. £50k was invested in ImmBio at attractive terms at the end of their successful trials. Finally we invested £34k in Scancell's placing and open AIM offer, the maximum we could make under VCT rules.


The Directors have reviewed the valuations of each investee company in the unquoted portfolio but have made only minor changes. In the AIM portfolio the Scancell price remained flat and the Abzena price declined from 49p to 41p per share. Based on the revised NAV at 31 August 2016, the performance fee accrual at 29 February 2016 of £23k has been reversed as the revised escalating performance fee threshold has now just increased above the current NAV.


Shareholders should remain aware that the portfolio is very concentrated with just three holdings representing about 65% of NAV. The value of the portfolio is thus very sensitive to changes in valuations of these three holdings: Ixaris, Glide and Scancell. The directors continue to take an active interest in the investee companies and look forward to continuing to work with OTM to maximise shareholder value and to secure profitable exits from these investee companies at the appropriate time and to enable further dividends to be paid.


Liquidity At period end we had net current assets of £1.03m. Post period end we have committed to invest in Arecor, Orthogem and Glide. VCT qualifying status The Board has procedures in place to ensure that the Company continues to comply with the conditions laid down by HMRC for maintaining approval as a VCT.


Presentation of half-yearly report In order to reduce the length of this report, we have omitted details of the Company's objectives and investment strategy, its Advisers and Registrars and how to buy and sell shares in the Company. These details are all included in the Annual Reports, which, together with previous half-yearly reports, are available for viewing on the Oxford Technology website. Outlook The last six months has seen a number of changes to qualification conditions for VCTs. However, as we are not looking to invest in new companies we do not believe that these changes will give rise to any issues for our Company. Likewise any uncertainties surrounding the departure from the EU are unlikely to affect us directly. We were pleased to welcome a large number of shareholders to our AGM in July. Three of our investee companies made presentations: Scancell, Ixaris and Plasma Antennas. These presentations are on the Oxford Technology website. The directors' view remains that the portfolio still holds significant potential over the medium term but is not without risk.  Finally I would like to take this opportunity to thank shareholders for their continued support.


Robin Goodfellow - Chairman 19 October 2016 Investment Portfolio as at 31 August 2016


+------------+--------------+----------+--------+------+------+------+--------- -+

|Company     |Description   |Net Cost  |Carrying|Change|%     |%     |%        
|
|            |              |of        |value at|in    |Equity|Equity|of fund  
|
|            |              |investment|31/8/16 |value |held  |held 
|investment|
|            |              |£'000     |£'000   |for   |OT3   |All OT|value    
|
|            |              |          |        |the 6 |      |      |         
|
|            |              |          |        |month |      |      |         
|
|            |              |          |        |period|      |      |         
|
|            |              |          |        |£'000 |      |      |         
| +------------+--------------+----------+--------+------+------+------+--------- -+
|Ixaris      |Internet      |   643    | 2,202  | 529  | 7.6  | 7.6  |   44.8  
|
|            |payments      |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|Glide       |Needle free   |   225    |  814   |  -   | 3.3  | 9.0  |   16.5  
|
|Technologies|injector      |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|Scancell    |Antibody based|   359    |  810   |  35  | 1.8  | 4.4  |   16.5  
|
|(bid price  |cancer        |          |        |      |      |      |         
|
|17.5p)      |therapeutics  |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|Plasma      |Directional   |   308    |  277   | 200  | 12.3 | 45.1 |   5.6   
|
|Antennas    |antennas      |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|ImmBio      |Novel vaccines|   400    |  237   |  50  | 4.4  | 13.9 |   4.8   
|
|            |              |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|Select      |Photocopier   |    47    |  147   |  3   | 2.8  | 58.5 |   3.0   
|
|Technology  |interfaces    |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|Allinea     |Parallel      |    15    |  146   | (16) | 1.9  | 1.9  |   3.0   
|
|Software    |computing     |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|Abzena      |Protein &     |    69    |   82   | (16) | 0.2  | 0.3  |   1.7   
|
|(bid price  |peptide based |          |        |      |      |      |         
|
|41p)        |drugs         |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|Arecor      |Protein       |    24    |   56   |  9   | 0.7  | 7.3  |   1.1   
|
|            |stabilisation |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|Insense     |Wound healing |   333    |   44   |  -   | 4.1  | 12.1 |   0.9   
|
|            |              |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|Orthogem    |Bone graft    |   134    |   42   |  -   | 4.0  | 14.6 |   0.9   
|
|            |material      |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|Inaplex     |Data          |    58    |   22   |  -   | 13.3 | 34.8 |   0.5   
|
|            |transformation|          |        |      |      |      |         
|
|            |software      |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|Invro       |Low power     |    40    |   20   |  -   | 33.1 | 33.1 |   0.4   
|
|            |electronics   |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|Metal       |Production of |   153    |   13   |  -   | 20.0 | 36.7 |   0.3   
|
|Nanopowders |metal powders |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|Superhard   |Production of |    11    |   5    |  -   | 21.8 | 40.0 |   0.1   
|
|Materials   |hard materials|          |        |      |      |      |         
| +------------+--------------+----------+--------+------+------+------+--------- -+
|Total       |              |  2,918   | 4,917  | 794  |      |      |   100%  
|
|Investments |              |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
| +------------+--------------+----------+--------+------+------+------+--------- -+
|Other Net   |              |          | 1,005  |      |      |      |         
|
|Assets      |              |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
| +------------+--------------+----------+--------+------+------+------+--------- -+
|Net Assets  |              |          | 5,922  |      |      |      |         
|
|            |              |          |        |      |      |      |         
|
|            |              |          |        |      |      |      |         
| +------------+--------------+----------+--------+------+------+------+--------- -+


Responsibility Statement of the Directors in respect of the half-yearly report


We confirm that to the best of our knowledge: * the half-yearly financial statements have been prepared in accordance with the statement "Interim Financial Reporting" issued by the Financial Reporting Council; * the half-yearly report includes a fair review of the information required by the Financial Services Authority Disclosure and Transparency Rules, being: * an indication of the important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements. * a description of the principal risks and uncertainties for the remaining six months of the year. * a description of related party transactions that have taken place in the first six months of the current financial year that may have materially affected the financial position or performance of the Company during that period and any changes in the related party transactions described in the last annual report that could do so.


On behalf of the Board: Robin Goodfellow - Chairman 19 October 2016 Income Statement


+------------+---------------------+---------------------+---------------------+

|            |Six months to 31 Aug |Six months to 31 Aug | Year to 29 February |
|            |        2016         |        2015         |        2016         |
|            |                     |                     |                     |
|            |Revenue Capital Total|Revenue Capital Total|Revenue Capital Total|
|            |                     |                     |                     |
|            |  £'000   £'000 £'000|  £'000   £'000 £'000|  £'000   £'000 £'000|
+------------+---------------------+---------------------+---------------------+
|            |                     |                     |                     |
|            |                     |                     |                     |
|Gain on     |                     |                     |                     |
|disposal of |                     |                     |                     |
|fixed asset |                     |                     |                     |
|investments |      -       -     -|      -       3     3|      -   1,333 1,333|
|            |                     |                     |                     |
|            |                     |                     |                     |
|            |                     |                     |                     |
|Gain/(Loss) |                     |                     |                     |
|on valuation|                     |                     |                     |
|of fixed    |                     |                     |                     |
|asset       |                     |                     |                     |
|investments |      -      85    85|      -     659   659|      -   (414) (414)|
|            |                     |                     |                     |
|            |                     |                     |                     |
|            |                     |                     |                     |
|Performance |                     |                     |                     |
|fee credit  |      -      23    23|      -      70    70|      -      72    72|
|            |                     |                     |                     |
|            |                     |                     |                     |
|            |                     |                     |                     |
|Other income|      -       -     -|      3       -     3|     19       -    19|
|            |                     |                     |                     |
|            |                     |                     |                     |
|            |                     |                     |                     |
|Investment  |                     |                     |                     |
|management  |                     |                     |                     |
|fees        |    (9)    (26)  (35)|    (8)    (24)  (32)|   (16)    (49)  (65)|
|            |                     |                     |                     |
|            |                     |                     |                     |
|Other       |                     |                     |                     |
|expenses    |   (27)       -  (27)|   (28)       -  (28)|   (62)       -  (62)|
|            |                     |                     |                     |
|            |                     |                     |                     |
+------------+---------------------+---------------------+---------------------+
|Return on   |                     |                     |                     |
|ordinary    |                     |                     |                     |
|activities  |                     |                     |                     |
|before tax  |   (36)      82    46|   (33)     708   675|   (59)     942   883|
|            |                     |                     |                     |
|            |                     |                     |                     |
|            |                     |                     |                     |
|Taxation on |                     |                     |                     |
|loss on     |                     |                     |                     |
|ordinary    |                     |                     |                     |
|activities  |      -       -     -|      -       -     -|      -       -     -|
|            |                     |                     |                     |
|            |                     |                     |                     |
+------------+---------------------+---------------------+---------------------+
|            |                     |                     |                     |
|            |                     |                     |                     |
|Return on   |                     |                     |                     |
|ordinary    |                     |                     |                     |
|activities  |                     |                     |                     |
|after tax   |   (36)      82    46|   (33)     708   675|   (59)     942   883|
+------------+---------------------+---------------------+---------------------+
|            |                     |                     |                     |
|            |                     |                     |                     |
|Earnings per|                     |                     |                     |
|share -     |                     |                     |                     |
|basic and   |                     |                     |                     |
|diluted     | (0.5)p    1.2p  0.7p| (0.5)p   10.4p  9.9p| (0.9)p   13.9p 13.0p|
+------------+---------------------+---------------------+---------------------+



* The 'Total' column of this statement is the profit and loss account of the Company; the supplementary Revenue return and Capital return columns have been prepared under guidance published by the Association of Investment Companies.


* All revenue and capital items in the above statement derive from continuing operations.


* The accompanying notes are an integral part of the half-yearly report.


* The Company has only one class of business and derives its income from investments made in shares and securities and from bank and money market funds.


The Company has no recognised gains or losses other than the results for the period as set out above. Accordingly a Statement of Comprehensive Income is not required.




Balance Sheet +-------------------------+---------------+---------------+--------------------+

|                         | As at 31 Aug  | As at 31 Aug  | As at 29 February  |
|                         |     2016      |     2015      |        2016        |
|                         |               |               |                    |
|                         |£'000     £'000|£'000     £'000|£'000          £'000|
+-------------------------+---------------+---------------+--------------------+
|                         |               |               |                    |
|                         |               |               |                    |
|Fixed asset investments *|          4,917|          7,077|               4,123|
|                         |               |               |                    |
|Current assets:          |               |               |                    |
|                         |               |               |                    |
|Debtors                  |   17          |  118          |    2               |
|                         |               |               |                    |
|Creditors:               |               |               |                    |
|                         |               |               |                    |
|Amounts falling due      |               |               |                    |
|within one year          | (52)          | (59)          | (55)               |
|                         |               |               |                    |
|Cash at Bank             |1,064          |  119          |2,894               |
+-------------------------+---------------+---------------+--------------------+
|Net current assets       |          1,029|            178|               2,841|
|                         |               |               |                    |
|                         |               |               |                    |
|                         |               |               |                    |
|Creditors:               |               |               |                    |
|Amounts falling due in   |               |               |                    |
|more than one year       |           (24)|           (71)|                (47)|
+-------------------------+---------------+---------------+--------------------+
|Provision for performance|               |               |                    |
|fee                      |              -|           (24)|                (23)|
|                         |               |               |                    |
|                         |               |               |                    |
+-------------------------+---------------+---------------+--------------------+
|Net assets               |          5,922|          7,160|               6,894|
+-------------------------+---------------+---------------+--------------------+
|                         |               |               |                    |
|                         |               |               |                    |
|Called up equity share   |               |               |                    |
|capital                  |            679|            679|                 679|
|                         |               |               |                    |
|                         |               |               |                    |
|                         |               |               |                    |
|Share premium            |            719|            719|                 719|
|                         |               |               |                    |
|                         |               |               |                    |
|                         |               |               |                    |
|Unrealised capital       |               |               |                    |
|reserve                  |          1,998|          4,912|               1,913|
|                         |               |               |                    |
|                         |               |               |                    |
|                         |               |               |                    |
|Profit and Loss account  |               |               |                    |
|reserve                  |          2,526|            850|               3,583|
|                         |               |               |                    |
|                         |               |               |                    |
+-------------------------+---------------+---------------+--------------------+
|Total equity             |               |               |                    |
|shareholders' funds      |          5,922|          7,160|               6,894|
|                         |               |               |                    |
|                         |               |               |                    |
+-------------------------+---------------+---------------+--------------------+
|Net asset value per share|          87.3p|         105.5p|              101.6p|
+-------------------------+---------------+---------------+--------------------+




* At fair value through profit and loss

























Statement of Changes in Equity



+----------------+-------------------------------------------------------------+

|                |                                             Profit &        |
|                |       Share        Share      Unrealised        Loss        |
|                |     Capital      Premium Capital Reserve     Reserve Total  |
|                |       £'000        £'000           £'000       £'000   £'000|
+----------------+-------------------------------------------------------------+
|                |                                                             |
|                |                                                             |
|As at 1 March   |                                                             |
|2015            |         679          719           4,315         773   6,486|
|                |                                                             |
|Revenue return  |                                                             |
|on ordinary     |                                                             |
|activities after|                                                             |
|tax             |           -            -               -        (33)    (33)|
|                |                                                             |
|Expenses        |                                                             |
|credited to     |                                                             |
|capital         |           -            -               -          46      46|
|                |                                                             |
|Current period  |                                                             |
|gains on        |                                                             |
|disposal        |           -            -               -           3       3|
|                |                                                             |
|Current period  |                                                             |
|gains on fair   |                                                             |
|value of        |                                                             |
|investments     |           -            -             659           -     659|
|                |                                                             |
|Prior years'    |                                                             |
|unrealised gains|                                                             |
|now realised    |           -            -            (62)          62       -|
|                |                                                             |
|Balance as at   |                                                             |
|31 August 2015  |         679          719           4,912         850   7,160|
+----------------+-------------------------------------------------------------+
|                |                                                             |
|                |                                                             |
|As at 1 March   |                                                             |
|2015            |         679          719           4,315         773   6,486|
|                |                                                             |
|Revenue return  |                                                             |
|on ordinary     |                                                             |
|activities after|                                                             |
|tax             |           -            -               -        (59)    (59)|
|                |                                                             |
|Expenses        |                                                             |
|credited to     |                                                             |
|capital         |           -            -               -          23      23|
|                |                                                             |
|Current period  |                                                             |
|gains on        |                                                             |
|disposal        |           -            -               -       1,333   1,333|
|                |                                                             |
|Current period  |                                                             |
|losses on fair  |                                                             |
|value of        |                                                             |
|investments     |           -            -           (414)           -   (414)|
|                |                                                             |
|Prior years'    |                                                             |
|unrealised gains|                                                             |
|now realised    |           -            -         (1,913)       1,913       -|
|                |                                                             |
|Dividends paid  |           -            -               -       (475)   (475)|
|                |                                                             |
|Movement in     |                                                             |
|reserves        |           -            -            (75)          75       -|
|                |                                                             |
|Balance as at   |                                                             |
|29 February 2016|         679          719           1,913       3,583   6,894|
+----------------+-------------------------------------------------------------+
|                |                                                             |
|                |                                                             |
|As at 1 March   |                                                             |
|2016            |         679          719           1,913       3,583   6,894|
|                |                                                             |
|Revenue return  |                                                             |
|on ordinary     |                                                             |
|activities after|                                                             |
|tax             |           -            -               -        (36)    (36)|
|                |                                                             |
|Expenses charged|                                                             |
|to capital      |           -            -               -         (3)     (3)|
|                |                                                             |
|Current period  |                                                             |
|gains on        |                                                             |
|disposal        |           -            -               -           -       -|
|                |                                                             |
|Current period  |                                                             |
|gains on fair   |                                                             |
|value of        |                                                             |
|investments     |           -            -              85           -      85|
|                |                                                             |
|Dividends paid  |           -            -               -     (1,018) (1,018)|
|                |                                                             |
|Balance as at   |                                                             |
|31 August 2016  |         679          719           1,998       2,526   5,922|
+----------------+-------------------------------------------------------------+




Statement of Cash Flows



+----------------------------+----------------+---------------+----------------+

|                            |   Six months to|  Six months to|     Year to 29 |
|                            |     31 Aug 2016|    31 Aug 2015|   February 2016|
|                            |                |               |                |
|                            |           £'000|          £'000|           £'000|
+----------------------------+----------------+---------------+----------------+
|Cash flows from operating   |                |               |                |
|activities                  |                |               |                |
|                            |                |               |                |
|Return on ordinary          |                |               |                |
|activities before tax       |              46|            675|             883|
|                            |                |               |                |
|Adjustments for:            |                |               |                |
|                            |                |               |                |
|Decrease/(increase) in      |                |               |                |
|debtors                     |            (15)|          (116)|             (1)|
|                            |                |               |                |
|(Decrease)/increase in      |                |               |                |
|creditors                   |            (49)|           (91)|           (119)|
|                            |                |               |                |
|Gain on disposal of fixed   |                |               |                |
|asset investments           |               -|            (3)|         (1,333)|
|                            |                |               |                |
|Loss/(gain) on valuation of |                |               |                |
|fixed asset                 |                |               |                |
|Investments                 |                |               |                |
|                            |            (85)|          (659)|             414|
+----------------------------+----------------+---------------+----------------+
|Net cash generated from     |                |               |                |
|operating activities        |           (103)|          (194)|           (156)|
+----------------------------+----------------+---------------+----------------+
|                            |                |               |                |
|                            |                |               |                |
|Cash flows from investing   |                |               |                |
|activities                  |                |               |                |
|                            |                |               |                |
|Purchase of fixed asset     |                |               |                |
|investments                 |           (709)|              -|           (120)|
|                            |                |               |                |
|Sale of fixed asset         |                |               |                |
|investments                 |               -|            110|           3,442|
+----------------------------+----------------+---------------+----------------+
|Total cash flows from       |                |               |                |
|investing activities        |           (709)|            110|           3,322|
|                            |                |               |                |
|                            |                |               |                |
+----------------------------+----------------+---------------+----------------+
|Cash flows from financing   |                |               |                |
|activities                  |                |               |                |
|                            |                |               |                |
|Dividends paid              |         (1,018)|              -|           (475)|
+----------------------------+----------------+---------------+----------------+
|Total cash flows from       |                |               |                |
|financing activities        |         (1,018)|              -|           (475)|
|                            |                |               |                |
|                            |                |               |                |
+----------------------------+----------------+---------------+----------------+
|Increase/(decrease) in cash |                |               |                |
|and cash equivalents        |         (1,830)|           (84)|           2,691|
|                            |                |               |                |
|                            |                |               |                |
|                            |                |               |                |
|Opening cash and cash       |                |               |                |
|equivalents                 |           2,894|            203|             203|
|                            |                |               |                |
|                            |                |               |                |
+----------------------------+----------------+---------------+----------------+
|Closing cash and cash       |                |               |                |
|equivalents                 |           1,064|            119|           2,894|
+----------------------------+----------------+---------------+----------------+





Notes to the Half-Yearly Report 1.         Basis of preparation The unaudited half-yearly results which cover the six months to 31 August 2016 have been prepared in accordance with the Financial Reporting Council's (FRC) Financial Reporting Standard 104 Interim Financial Reporting ('FRS 104') and the Statement of Recommended Practice (SORP) for Investment Companies re-issued by the Association of Investment Companies in November 2014. Details of the accounting policies and valuation methodologies are included in the Annual Report.


2.         Publication of non-statutory accounts The unaudited half-yearly results for the six months ended 31 August 2016 do not constitute statutory accounts within the meaning of Section 415 of the Companies Act 2006. The comparative figures for the year ended 29 February 2016 have been extracted from the audited financial statements for that year, which have been delivered to the Registrar of Companies. The independent auditor's report on those financial statements, in accordance with chapter 3, part 16 of the Companies Act 2006, was unqualified. This half-yearly report has not been reviewed by the Company's auditor.


3.         Earnings per share The calculation of earnings per share for the period is based on the return attributable to shareholders divided by the weighted average number of shares in issue during the period. There are no potentially dilutive capital instruments in issue and, therefore, no diluted returns per share figures are relevant.


4.         Net asset value per share The net asset value per share is based on the net assets at the period end divided by the number of shares in issue at that date (6,785,233 in each case).


5.         Principal risks and uncertainties The Company's assets consist of equity and fixed interest investments, cash and liquid resources. Its principal risks are therefore market risk, credit risk and liquidity risk. Other risks faced by the Company include economic, loss of approval as a Venture Capital Trust, investment and strategic, regulatory, reputational, operational and financial risks. These risks, and the way in which they are managed, are described in more detail in the Company's Annual Report and Accounts for the year ended 29 February 2016. The Company's principal risks and uncertainties have not changed materially since the date of that report.


6.         Related party transactions OT3 Managers Ltd, a wholly owned subsidiary, provides investment management services to the Company for a fee of 1% of net assets per annum.


7.         Copies of this statement are available from Oxford Technology Management, The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA and on the Company's website - www.oxfordtechnology.com/vct3.




Board Directors: Robin Goodfellow, Richard Roth, Alex Starling and David Livesley



Investment Manager: OT3 Managers Ltd with services contracted to Oxford Technology Management Ltd Website: www.oxfordtechnology.com/vct3





This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.


Source: Oxford Technology 3 VCT plc via GlobeNewswire



3142039R27


Copyright RTT News/dpa-AFX



MMMM





 
 

Aktien des Tages
  


Mit der Anmeldung für den Newsletter "Aktien des Tages" stimme ich dem gleichzeitigen Erhalt des "GeVestor täglich" unseres Partners GeVestor zu.


Mit der Anmeldung für den Newsletter "Aktien des Tages" stimme ich dem gleichzeitigen Erhalt des "Investors Daily" unseres Partners FID Verlag zu.

RSS Feeds




Bitte warten...